MicroRNA Regulation of Chronic Inflammation During Aging

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorUniversity of Utah

About this trial

This is an observational study enrolling healthy individuals aged 18-35 and 65y and older to determine the health of immune cells in the blood and how these cells create inflammation and effect health as we age. It is hoped that once the nature of this relationship has been discovered we can more effectively design therapies to reduce this inflammation.

The enrollment goal is 40 participants. The study will occur over the course of 1 month which will include a screening visit and a second visit where the participants will undergo an oral glucose tolerance test, blood draws and leg strength \& exercise tests.

Eligibility criteria

Qualifiers

Age between 18 - 35y; 65y and older

BMI: <30 kg/m2

Ability to sign informed consent

For older participant group: Clinical Frailty Scale score < 3 and Mini-Cog score > 3

Disqualifiers

History of cardiovascular disease (e.g., CHF, CAD, MI, CVA)

History of endocrine or metabolic disease such as hypo/hyperthyroidism and diabetes (Treated hypo/hyperthyroid for at least 6 months will be permitted)

History of kidney disease or failure (CKD > stage 4)

History of vascular disease

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

40 Participants
are grouped into 2 trial groups

Sponsors and collaborators